BRR : 10477487
Tender Brief : Supply Of , Gliclazide Mr 30 Mg Tab , Glibenclamide 5Mg Tab , Vildagliptin 50Mg Tab , Insulin Highly Purified Human Neutral40iu / Ml, 10 Ml Inj , Insulin Highly Purified Isophane ( Human Nph ) 40Iu / Ml, 10 Ml Inj , Tab Empagliflozin 10 Mg , Metformin 0.5G Tab , Thyroxine Sodium 0.025 Mg Tab , Thyroxine Sodium 0.1Mg Tab , Atracurium 10 Mg / Ml, 2.5 Ml Inj , Neostigmine 0.5 Mg, 1 Ml Inj , Pancuronium Bromide 2 Mg / Ml, 2 Ml Inj , Succinylchloline Chloride 50 Mg / Ml, 2 Ml Inj , Vecuronium Bromide4mg / Ml, 1 Ml Inj , Cisatracurium 2 Mg / Ml Inj, 10 Ml Vial , Calcium Pol... Read More
Tender Value
₹
Ref. Document
Submission Date
18-08-2021
Participated Bidder List
21 No of Bidder(s)
| Sr No. | Bidder Name | Bid Analytics | Technical Bid | Financial Bid | AOC | Bid Value | Rank |
|---|---|---|---|---|---|---|---|
| 1 | cnet-technologies | Bid Analytics | 72,390 | L6 | |||
| 2 | cnet-technologies | Bid Analytics | 1,32,735.27 | L1 | |||
| 3 | cnet-technologies | Bid Analytics | 68,250 | L5 | |||
| 4 | cnet-technologies | Bid Analytics | 5,83,781.94 | L1 | |||
| 5 | cnet-technologies | Bid Analytics | 1,57,114.5 | L1 | |||
| 6 | cnet-technologies | Bid Analytics | 2,69,852.46 | L7 | |||
| 7 | cnet-technologies | Bid Analytics | 29,341.56 | L1 | |||
| 8 | cnet-technologies | Bid Analytics | 26,219.7 | L1 | |||
| 9 | cnet-technologies | Bid Analytics | 1,20,057 | L1 | |||
| 10 | cnet-technologies | Bid Analytics | 26,354.7 | L1 | |||
| 11 | cnet-technologies | Bid Analytics | 7,52,052.12 | L8 | |||
| 12 | cnet-technologies | Bid Analytics | 86,663.34 | L1 | |||
| 13 | cnet-technologies | Bid Analytics | 27,564 | L1 | |||
| 14 | cnet-technologies | Bid Analytics | |||||
| 15 | cnet-technologies | Bid Analytics | 1,08,170.31 | L1 | |||
| 16 | cnet-technologies | Bid Analytics | 49,840.5 | L3 | |||
| 17 | cnet-technologies | Bid Analytics | 3,16,052.85 | L1 | |||
| 18 | cnet-technologies | Bid Analytics | 58,452.9 | L4 | |||
| 19 | cnet-technologies | Bid Analytics | 33,216 | L2 | |||
| 20 | cnet-technologies | Bid Analytics | 1,63,872 | L1 | |||
| 21 | cnet-technologies | Bid Analytics | 24,265.62 | L1 |
Work Detail
supply of , gliclazide mr 30 mg tab , glibenclamide 5mg tab , vildagliptin 50mg tab , insulin highly purified human neutral40iu / ml, 10 ml inj , insulin highly purified isophane ( human nph ) 40iu / ml, 10 ml inj , tab empagliflozin 10 mg , metformin 0.5g tab , thyroxine sodium 0.025 mg tab , thyroxine sodium 0.1mg tab , atracurium 10 mg / ml, 2.5 ml inj , neostigmine 0.5 mg, 1 ml inj , pancuronium bromide 2 mg / ml, 2 ml inj , succinylchloline chloride 50 mg / ml, 2 ml inj , vecuronium bromide4mg / ml, 1 ml inj , cisatracurium 2 mg / ml inj, 10 ml vial , calcium polystryne sulphate powder , protein supplement for predialysis renal failure , protein supplement for renal patients on hemodialysis / capd , papaverine hydrochloride 50 mg, 2 ml inj , ciprofloxacin 0.3% eye drops of 3mg / ml bott of 5 ml , ciprofloxacin hcl 0.3% tube of 5 gm , ciprofloxacin hcl 0.3% + dexamethasone 0.1 % bott of 5ml , fluconazole 0.3% w / v bott of 5 ml , flurbiprofen sodium ophthalmic solution 0.03% vial of 5 ml , gatifloxacin 0.3% eye drop bott of 5 ml , gentamicin sulphate 0.3% w / v gentamicin base with hydrocortisone acetate ip 1% w / v eye & ear drops bott of 5 ml , moxifloxacin 0.5% preservative free eye drops , lignocaine hyrochloride 4% topical solution bott of 30 ml , carboxy methyl cellulose ( cmc ) 1% gel , ofloxacin 0.3% bott of 5 ml , tobramycin 0.3% bott of 5 ml , syp diphenhydramine 10-15 mg per 5 ml and ammonium chloride 100 -150 mg, sodium citrate 50-85 mg per 5 ml, bottle of 100 ml , cinnarizine 25 mg tab , prochlorperazine maleate 5mg tab , chloramphenicol 5% w / v, clotrimazole 1% w / v, betamethasone 0.25 % w / v, lignocaine hcl 2% w / v in bott of 5 ml , xylometazoline hcl 0.05% w / v nasal solution for paed use bott of 10ml , salmeterol 25 mcg+ fluticasone 250 mcgmdi 120 doses with dose counter , cetrizine syp 5mg / 5ml bott of 60 ml , frusemide 10 mg / ml 30 ml syp , domperidone syp 1 mg / ml bott of 30 ml
View Original Notice/Document
Result Documents
Tender Documents
Disclaimer
We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender
Financial Evaluation In Progress
Financial bids are currently under review. Awarded bidder information will be published after final evaluation.
PriceBid
Similar Tenders Results